×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for Dyne Therapeutics, Inc. (DYN)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerMar 08, 2024Sale$26.6727,199725,344159,383Mar 13, 2024, 06:04 AM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerMar 11, 2024Sale$25.702,29258,904156,800Mar 13, 2024, 06:04 AM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerMar 08, 2024Sale$15.89180,0002,860,131231,184Mar 13, 2024, 06:04 AM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerMar 11, 2024Sale$15.9937,426598,592159,009Mar 13, 2024, 06:04 AM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerMar 11, 2024Sale$25.701,58540,735151,590Mar 12, 2024, 09:58 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerMar 12, 2024Sale$25.581,03026,347150,560Mar 12, 2024, 09:58 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 08, 2024Sale$15.88172,5042,739,301208,207Mar 12, 2024, 09:57 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 11, 2024Sale$25.282,67267,542120,873Mar 12, 2024, 09:57 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 08, 2024Sale$15.74726,68611,434,554917,728Mar 12, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 11, 2024Sale$17.02116,3871,981,142604,385Mar 12, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerMar 11, 2024Sale$25.702,08153,482152,352Mar 12, 2024, 09:42 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 07, 2024Sale$25.859,086234,873554,385Mar 11, 2024, 09:57 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerMar 07, 2024Sale$25.852,37361,342154,433Mar 11, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerMar 07, 2024Sale$25.851,59141,127186,291Mar 11, 2024, 09:56 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerMar 07, 2024Sale$25.869,921256,585154,732Mar 11, 2024, 09:52 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerMar 07, 2024Sale$25.852,43462,919141,184Mar 11, 2024, 09:50 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 07, 2024Sale$25.852,27358,757121,955Mar 11, 2024, 09:45 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorMar 01, 2024Sale$30.0546,5341,398,3471,458,691Mar 05, 2024, 05:08 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LP10% OwnerMar 01, 2024Sale$30.0529,435884,5221,458,691Mar 05, 2024, 05:07 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LP10% OwnerMar 01, 2024Sale$30.0517,099513,825847,388Mar 05, 2024, 05:07 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentFeb 29, 2024Option Exercise$16.5211,040182,381568,991Mar 01, 2024, 09:38 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentMar 01, 2024Sale$17.29188,9603,267,138657,951Mar 01, 2024, 09:38 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerFeb 29, 2024Option Exercise$14.128,536120,486147,886Mar 01, 2024, 09:37 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerMar 01, 2024Sale$14.6848,520712,205167,878Mar 01, 2024, 09:37 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Feb 29, 2024Option Exercise$14.266,85897,829127,657Mar 01, 2024, 09:37 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01, 2024Sale$14.6418,622272,589133,539Mar 01, 2024, 09:37 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 26, 2024Sale$23.72248,2195,886,6736,216,250Feb 28, 2024, 07:15 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 27, 2024Sale$24.41368,6998,998,4265,878,544Feb 28, 2024, 07:15 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 28, 2024Sale$24.84190,9204,741,8045,700,521Feb 28, 2024, 07:15 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LP10% OwnerFeb 28, 2024Sale$24.8436,246900,2281,488,486Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 26, 2024Sale$23.72201,0954,769,0966,216,250Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 26, 2024Sale$23.7247,1241,117,5771,564,932Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LP10% OwnerFeb 27, 2024Sale$24.41298,7027,290,0885,878,544Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 27, 2024Sale$24.4169,9971,708,3381,514,874Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LLC10% OwnerFeb 28, 2024Sale$24.84154,6743,841,5765,700,521Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerFeb 28, 2024Sale$25.0040710,175163,096Feb 28, 2024, 05:06 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 22, 2024Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:59 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 23, 2024Sale$22.70196,9284,470,2666,352,562Feb 23, 2024, 06:59 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 21, 2024Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:59 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund I, L.P.10% OwnerFeb 21, 2024Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 22, 2024Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates Opportunity II, LLC10% OwnerFeb 23, 2024Sale$22.70159,5423,621,6046,352,562Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Opportunity Fund I, L.P.10% OwnerFeb 23, 2024Sale$22.7037,386848,6621,585,137Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 15, 2024Sale$23.89177,9064,249,6007,150,324Feb 20, 2024, 06:36 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 16, 2024Sale$23.14162,7073,765,0406,985,504Feb 20, 2024, 06:36 PM
DYNDyne Therapeutics, Inc.Rhodes Jason PDirectorFeb 20, 2024Sale$22.72169,5393,852,6526,819,475Feb 20, 2024, 06:36 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 20, 2024Sale$22.72169,5393,852,6526,819,475Feb 20, 2024, 06:35 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 15, 2024Sale$23.89177,9064,249,6007,150,324Feb 20, 2024, 06:35 PM
DYNDyne Therapeutics, Inc.Atlas Venture Associates XI, LLC10% OwnerFeb 16, 2024Sale$23.14162,7073,765,0406,985,504Feb 20, 2024, 06:35 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerFeb 12, 2024Sale$25.075,493137,710163,503Feb 14, 2024, 04:27 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerJan 26, 2024Sale$25.001002,500168,996Jan 26, 2024, 07:49 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerJan 26, 2024Sale$12.6340,000505,110163,618Jan 26, 2024, 07:48 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 26, 2024Sale$12.6926,000329,810137,228Jan 26, 2024, 07:47 PM
DYNDyne Therapeutics, Inc.Kersten DirkDirectorJan 09, 2024Buy$17.501,714,28529,999,9886,416,793Jan 11, 2024, 04:31 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentJan 03, 2024Sale$10.16102,3661,039,676636,154Jan 04, 2024, 09:49 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TCEO & PresidentJan 04, 2024Sale$11.84437,0725,173,050803,507Jan 04, 2024, 09:49 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerJan 04, 2024Option Exercise$12.1865,127793,027199,259Jan 04, 2024, 09:48 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerJan 03, 2024Sale$10.0190,652906,998221,911Jan 04, 2024, 09:48 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerJan 02, 2024Sale$13.1011,900155,890143,618Jan 04, 2024, 09:47 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerJan 03, 2024Sale$9.7335,982350,195161,609Jan 04, 2024, 09:47 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerJan 04, 2024Option Exercise$9.394,01837,709145,627Jan 04, 2024, 09:47 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSVP, Head of Finance & Admin.Jan 03, 2024Sale$9.9226,000257,920137,228Jan 04, 2024, 09:46 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksDec 14, 2023Sale$12.022,37628,560124,228Dec 14, 2023, 04:59 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksDec 11, 2023Sale$10.721,38014,794126,604Dec 12, 2023, 05:35 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerDec 11, 2023Sale$10.721,24513,346155,518Dec 12, 2023, 05:34 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerDec 11, 2023Sale$10.721,61617,324187,882Dec 12, 2023, 05:34 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerDec 12, 2023Sale$10.5597810,318169,096Dec 12, 2023, 05:33 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerDec 11, 2023Sale$10.721,68818,095170,074Dec 12, 2023, 05:33 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksDec 11, 2023Sale$10.727,58581,311584,971Dec 12, 2023, 05:33 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerDec 11, 2023Sale$10.721,46715,726176,585Dec 12, 2023, 05:32 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksDec 04, 2023Sale$12.016818,179129,856Dec 06, 2023, 06:13 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksDec 06, 2023Sale$12.011,87222,483127,984Dec 06, 2023, 06:13 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerNov 02, 2023Sale$7.409,93973,54994,605Nov 02, 2023, 05:16 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksSep 18, 2023Sale$9.411,29012,13940,795Sep 20, 2023, 04:49 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerSep 18, 2023Sale$9.411,26111,86660,605Sep 20, 2023, 04:49 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerSep 18, 2023Sale$9.412,67225,144104,544Sep 20, 2023, 04:48 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 18, 2023Sale$9.4112,032113,221233,679Sep 20, 2023, 04:47 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerSep 18, 2023Sale$9.411,43613,51384,334Sep 20, 2023, 04:47 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerSep 12, 2023Sale$10.411,70717,77089,250Sep 13, 2023, 07:56 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksSep 12, 2023Sale$10.411,39714,54342,085Sep 13, 2023, 07:53 PM
DYNDyne Therapeutics, Inc.McNeill JonathanChief Business OfficerSep 12, 2023Sale$10.411,26613,17961,866Sep 13, 2023, 07:53 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerSep 12, 2023Sale$10.411,63517,020107,216Sep 13, 2023, 07:51 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksSep 12, 2023Sale$10.417,67279,866245,711Sep 13, 2023, 07:50 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerSep 12, 2023Sale$10.411,48415,44885,770Sep 13, 2023, 07:50 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksJun 13, 2023Sale$7.0581,390574,07893,482Jun 15, 2023, 05:46 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksJun 15, 2023Sale$12.0310,000120,30043,482Jun 15, 2023, 05:46 PM
DYNDyne Therapeutics, Inc.McNeill JonathanSee RemarksJun 12, 2023Sale$13.001,00013,00064,391Jun 14, 2023, 06:40 PM
DYNDyne Therapeutics, Inc.McNeill JonathanSee RemarksJun 13, 2023Sale$12.431,25915,64963,132Jun 14, 2023, 06:40 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerJun 13, 2023Sale$12.431,62520,199108,851Jun 14, 2023, 06:40 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerJun 13, 2023Sale$12.431,69821,10690,957Jun 14, 2023, 06:40 PM
DYNDyne Therapeutics, Inc.Beskrovnaya OxanaChief Scientific OfficerJun 13, 2023Sale$12.431,47518,33487,254Jun 14, 2023, 06:39 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 08, 2023Sale$9.2091,088837,681330,771Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 09, 2023Option Exercise$7.19153,1641,100,483346,353Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksJun 12, 2023Option Exercise$7.08359,1082,544,003441,131Jun 12, 2023, 09:22 PM
DYNDyne Therapeutics, Inc.Scalzo Richard WilliamSee RemarksMar 14, 2023Sale$13.331,31117,47654,872Mar 15, 2023, 05:51 PM
DYNDyne Therapeutics, Inc.McNeill JonathanSee RemarksMar 13, 2023Sale$13.001,00013,00066,600Mar 15, 2023, 05:50 PM
DYNDyne Therapeutics, Inc.McNeill JonathanSee RemarksMar 14, 2023Sale$13.331,20916,11665,391Mar 15, 2023, 05:50 PM
DYNDyne Therapeutics, Inc.HIGH SUSANNA GATTIChief Operating OfficerMar 14, 2023Sale$13.331,55920,781110,476Mar 15, 2023, 05:50 PM
DYNDyne Therapeutics, Inc.Farwell WildonChief Medical OfficerMar 14, 2023Sale$13.337,44199,18992,655Mar 15, 2023, 05:49 PM
DYNDyne Therapeutics, Inc.Brumm Joshua TSee RemarksMar 14, 2023Sale$13.337,31897,549322,483Mar 15, 2023, 05:49 PM